Genetic analysis of N-acetyltransferase polymorphism in a Chinese population

被引:7
作者
Lu, JF [1 ]
Cao, XM
Liu, ZH
Cao, W
Guo, LQ
Zhuo, HT
Ling, SS
Chen, YL
Zhao, Q
Wang, WP
Li, FQ
机构
[1] Jinling Hosp, Dept Clin Pharmacol, Nanjing 210002, Peoples R China
[2] Jinling Hosp, Mol Biol Lab, Nanjing 210002, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 1998年 / 19卷 / 04期
关键词
N-acetyltransferases; polymorphism (genetics); genotype; Chinese; alleles; polymerase chain reaction;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
AIM: To study the genetic basis of N-acetylatransferase polymorphism in Chinese. METHODS: Genotypes in 120 healthy Han volunteers from 19 provinces of China were assayed. The 3 common mutant alleles (M1, M2, M3) and one normal wild-type (WT) allele of the N-acetyltransferase (NAT2) gene were detected by allele-specific polymerase chain reaction technique. RESULTS: The NAT2 allele frequencies in 120 Chinese (WT = 0.625, M1 = 0.0458, M2 = 0.188, M3 = 0.142) were different (P < 0.01). The NAT2 genotype distribution for all detected combinations of NAT2 alleles in 120 Chinese subjects was consisitent with Hardy-Weinberg equilibrium (chi(2) = 7. 27, v = 8, 0.7 > P > 0.5). Fifty subjects (41.7 %) were homozygous wildtypes, 50 subjects (41.7 %) were heterozygous mutants, and 20 subjects (16.7 %) were homozygous mutants. CONCLUSION: The lower frequency of mutant M1 allele compared with that of Caucasians explains the low frequency of slow acylators in Chinese.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 12 条
[1]
GENOTYPE-PHENOTYPE DISCORDANCE FOR HUMAN ARYLAMINE N-ACETYLTRANSFERASE (NAT2) REVEALS A NEW SLOW-ACETYLATOR ALLELE COMMON IN AFRICAN-AMERICANS [J].
BELL, DA ;
TAYLOR, JA ;
BUTLER, MA ;
STEPHENS, EA ;
WIEST, J ;
BRUBAKER, LH ;
KADLUBAR, FF ;
LUCIER, GW .
CARCINOGENESIS, 1993, 14 (08) :1689-1692
[2]
MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS [J].
BLUM, M ;
DEMIERRE, A ;
GRANT, DM ;
HEIM, M ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5237-5241
[3]
HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[4]
CASCORBI I, 1995, AM J HUM GENET, V57, P581
[5]
DEGUCHI T, 1992, J BIOL CHEM, V267, P18140
[6]
LIN HJ, 1993, AM J HUM GENET, V52, P827
[7]
MAASHIMO M, 1992, HUM GENET, V90, P139
[8]
Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer [J].
Nebert, DW ;
McKinnon, RA ;
Puga, A .
DNA AND CELL BIOLOGY, 1996, 15 (04) :273-280
[9]
Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism [J].
Okumura, K ;
Kita, T ;
Chikazawa, S ;
Komada, F ;
Iwakawa, S ;
Tanigawara, Y .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (05) :509-517
[10]
CORRELATION BETWEEN N-ACETYLTRANSFERASE ACTIVITY AND NAT2 GENOTYPE IN CHINESE MALES [J].
ROTHMAN, N ;
HAYES, RB ;
BI, WF ;
CAPORASO, N ;
BROLY, F ;
WOOSLEY, RL ;
YIN, SN ;
FENG, PW ;
YOU, XJ ;
MEYER, UA .
PHARMACOGENETICS, 1993, 3 (05) :250-255